Key points
- Jeremie Fastnacht argues flavour and fragrance drive why people buy products more than advertising, packaging or price, making Givaudan a largely unseen business.
- Fastnacht says clients rarely change successful formulas because a 1% change saves little and carries safety and brand risk, creating high switching costs.
- Fastnacht calls Givaudan's stock, at about 23 times free cash flow with only about 3% implied growth, too low for a business with 5% organic growth history.
Givaudan earns durable margins selling scents clients rarely replace
Givaudan sells flavours and scents that decide whether consumers love a product, yet they cost clients only 1 to 5% of their spend. Winning formulas rarely get replaced, so revenue recurs and margins hold. A concentrated market and heavy R&D keep rivals competing on innovation rather than price.
Takeaways
- Scent and taste drive why people buy products. Fastnacht says studies show flavour and fragrance matter more to why people love a product than advertising, packaging or price. Givaudan ingredients sit in tens of thousands of products, making the industry a staples business but better, with defensive recurring demand.
- Switching costs lock in clients once formulas win. Clients send a brief with a target price, and three or four suppliers pitch unpaid. The winning compound is unique and stays with the supplier, like a royalty with upfront cost. A 1% saving rarely justifies the safety and brand risk of changing.
- Tiny cost share gives pricing resilience. Flavour is about 1% of a client's cost and fragrance about 5%, so procurement pushes for rebates, while suppliers negotiate to pass on raw material inflation. Selling something critical for a small share of cost gives durable margins and visibility.
- Concentrated fragrance market rewards scale and innovation. Givaudan, Firmenich, IFF and Symrise hold about two-thirds of fragrance, while flavour leaders hold around 10% each. Rivals compete on innovation, not price. Givaudan loses about 10% of revenue yearly, so it needs 15% new products to grow 5%.
- Givaudan leads on scale, IP and talent. It holds about 25% of fine fragrance and 10 to 15% of flavour. It spends about 8% of sales on R&D and holds 5,000 patents. Fragrance and beauty margin is rising to 27%, while taste and wellbeing holds near 22%.
- Steady growth and cash, but valuation implies little. Organic growth ran about 5% before COVID, typically 4% volume and 1% price, with no negative year since the IPO. Operating margin is 18 to 19% and free cash flow tops 1bn francs. At 23 times free cash flow, Fastnacht sees only 3% growth priced in.
How Givaudan became the leader
- In 1895 brothers Léon and Xavier Givaudan found a perfume factory in Zurich, then move to Vernier and pioneer synthetic perfume in large quantity.
- In 1948 it buys Esrolko to enter flavour.
- In the 1960s Roche acquires Givaudan and Roure of Grasse, and merges them in the 1990s.
- In 2000 it is spun off and listed on the Swiss exchange.
- In the early 2000s it buys Nestlé Food Ingredients, and later Quest International from Unilever.